Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Total 13F shares
-
24,080,381
-
Share change
-
-156,260
-
Total reported value
-
$332,562,030
-
Price per share
-
$13.81
-
Number of holders
-
105
-
Value change
-
-$1,269,800
-
Number of buys
-
37
-
Number of sells
-
56
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2014
As of 31 Dec 2014 LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) had 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,080,381 shares of stock of the company.
Largest 10 holders included WYNNEFIELD CAPITAL INC, DIMENSIONAL FUND ADVISORS LP, GUGGENHEIM CAPITAL LLC, ARIEL INVESTMENTS, LLC, NWQ INVESTMENT MANAGEMENT COMPANY, LLC, KILLEN GROUP INC, Boston Partners, ROYCE & ASSOCIATES LLC, BlackRock Institutional Trust Company, N.A., and ROYAL BANK OF CANADA.
This table shows 105 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.